The growth of the extracorporeal membrane oxygenation (ECMO) system market can be contributed to the growing cardiovascular and respiratory disease burden, rising adoption of ECMO as a bridge to lung transplantation, growing number of ECMO centers, conferences, and training programs to increase awareness, and increasing technological advancements. According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death across the world. Approximately 17.9 million people died due to cardiovascular diseases globally in 2016, and it accounted for almost 31%of all the deathsworldwide. In addition, the rising geriatric population and the increasing number of people suffering from diseases in populous countries, such as India and China, are the factors that are expected to offer significant growth opportunities for ECMO systems. Furthermore, the rising popularity of ECMO, due to its increasing applications and the upcoming new advancements in the products, is expected to act as a key contributor in the market’s growth. According to the study of Cureus, the ECMO therapy is observed to be a quite efficient technique in patients suffering from cardiogenic shock and cardiac arrest. It is a preferred therapy and the outcomes are found to be effective in cases of pulmonary embolismand pulmonary hypertension.

1. INTRODUCTION

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

5. MARKET SEGMENTATION

6. COMPANY PROFILES AND COMPETITIVE LANDSCAPE

7. MARKET OPPORTUNITIES AND FUTURE TRENDS